HomeADMA • NASDAQ
add
ADMA Biologics Inc
Previous close
$19.21
Day range
$19.00 - $19.48
Year range
$13.50 - $25.67
Market cap
4.34B USD
Avg Volume
3.70M
P/E ratio
22.58
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 134.22M | 12.00% |
Operating expense | 24.61M | 22.94% |
Net income | 36.43M | 1.45% |
Net profit margin | 27.14 | -9.41% |
Earnings per share | 0.16 | 6.01% |
EBITDA | 53.04M | 27.56% |
Effective tax rate | 23.33% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 61.38M | -29.20% |
Total assets | 568.69M | 45.59% |
Total liabilities | 137.50M | -13.37% |
Total equity | 431.19M | — |
Shares outstanding | 238.00M | — |
Price to book | 10.61 | — |
Return on assets | 22.63% | — |
Return on capital | 25.60% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 36.43M | 1.45% |
Cash from operations | 13.29M | -46.89% |
Cash from investing | -14.37M | -1,208.56% |
Cash from financing | -27.82M | -9.26% |
Net change in cash | -28.90M | -1,780.29% |
Free cash flow | -29.25M | -354.71% |
About
Founded
2004
Headquarters
Website
Employees
685
